These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3184372)

  • 1. Study of i.v. drug users and AIDS finds differing infection rate, risk behaviors.
    Raymond CA
    JAMA; 1988 Dec; 260(21):3105. PubMed ID: 3184372
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vertical transmission of HIV infection: descriptive epidemiology, risk factors and survival].
    Casabona Barbara J; Sánchez Ruiz E; Salas Ibáñez T; Curell Aguilá N; Fortuny Guasch C; Martí Gaudes C; Rodes Monegal A
    An Esp Pediatr; 1992 Nov; 37(5):367-71. PubMed ID: 1456617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV seroprevalence in intravenous drug users: Los Angeles, California, 1986.
    Mascola L; Lieb L; Iwakoshi KA; McAllister D; Siminowski T; Giles M; Run G; Fannin SL; Strantz IH
    Am J Public Health; 1989 Jan; 79(1):81-2. PubMed ID: 2909190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of HIV-1 infection among injection drug users in Montreal, 1985-1987.
    Lamothe F; Bruneau J; Soto J; Brabant M; Vincelette J
    Can Dis Wkly Rep; 1988 Dec; 14(50):225-7. PubMed ID: 3242908
    [No Abstract]   [Full Text] [Related]  

  • 5. Coordinated community programs for HIV prevention among intravenous-drug users--California, Massachusetts.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1989 Jun; 38(21):369-74. PubMed ID: 2497335
    [No Abstract]   [Full Text] [Related]  

  • 6. [HIV status and risk behavior among imprisoned intravenous drug addicts in Stockholm].
    Olin R; Käll K
    Lakartidningen; 1988 Feb; 85(5):334-9. PubMed ID: 3352415
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV infection in Baltimore: antibody seroprevalence rates among parenteral drug abusers and prostitutes.
    Lange WR; Snyder FR; Lozovsky D; Kaistha V; Kaczaniuk MA; Jaffe JH
    Md Med J; 1987 Sep; 36(9):757-61. PubMed ID: 3683103
    [No Abstract]   [Full Text] [Related]  

  • 8. [Epidemiology and transmission of HIV infection].
    Lüthy R
    Schweiz Rundsch Med Prax; 1988 Nov; 77(44):1183-5. PubMed ID: 3238242
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of antibodies to human immunodeficiency virus among intravenous drug users in Israel--association with travel abroad.
    Dan M; Rock M; Bar-Shany S
    Int J Epidemiol; 1989 Mar; 18(1):239-41. PubMed ID: 2722371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HIV infection among drug users in Amsterdam: prevalence and risk factors].
    van den Hoek JA; van Haastrecht HJ; van Zadelhoff AW; Goudsmit J; Coutinho RA
    Ned Tijdschr Geneeskd; 1988 Apr; 132(16):723-8. PubMed ID: 3374653
    [No Abstract]   [Full Text] [Related]  

  • 11. [The HIV patient in the surgical emergency unit].
    Bessler SC; Joller-Jemelka HI
    Schweiz Rundsch Med Prax; 1989 Mar; 78(10):254-9. PubMed ID: 2704921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV seropositivity and IVDUs: ethnic/gender comparisons.
    Lewis DK; Watters JK
    Am J Public Health; 1988 Nov; 78(11):1499. PubMed ID: 3177735
    [No Abstract]   [Full Text] [Related]  

  • 13. A seroepidemiologic profile of persons seeking anonymous HIV testing at alternate sites in upstate New York.
    Grabau JC; Truman BI; Morse DL
    N Y State J Med; 1988 Feb; 88(2):59-62. PubMed ID: 3344102
    [No Abstract]   [Full Text] [Related]  

  • 14. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.
    Selwyn PA; Hartel D; Lewis VA; Schoenbaum EE; Vermund SH; Klein RS; Walker AT; Friedland GH
    N Engl J Med; 1989 Mar; 320(9):545-50. PubMed ID: 2915665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leads from the MMWR. Quarterly report to the Domestic Policy Council on the prevalence and rate of spread of HIV and AIDS in the United States.
    JAMA; 1988 May; 259(18):2657, 2661. PubMed ID: 2833629
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City.
    Marmor M; Des Jarlais DC; Cohen H; Friedman SR; Beatrice ST; Dubin N; el-Sadr W; Mildvan D; Yancovitz S; Mathur U
    AIDS; 1987 May; 1(1):39-44. PubMed ID: 3122788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV infection among intravenous drug users: epidemiology and risk reduction.
    Des Jarlais DC; Friedman SR
    AIDS; 1987 Jul; 1(2):67-76. PubMed ID: 3130084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of HIV infection and risk behavior among drug users].
    Bachiller Luque P; Navarro Cañadas C; Muñoz Núñez P; Alvarez Hurtado AA
    Med Clin (Barc); 2000 Apr; 114(16):637-9. PubMed ID: 10846693
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of HIV infection in i.v. drug users.
    Stojda RJ
    Image J Nurs Sch; 1988; 20(2):115. PubMed ID: 3378817
    [No Abstract]   [Full Text] [Related]  

  • 20. Entry of HIV infection into the intravenous drug abusing population.
    Martin DJ; Schoub BD
    S Afr Med J; 1989 Apr; 75(7):349. PubMed ID: 2928890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.